DOI QR코드

DOI QR Code

Long-Term Outcomes in Stage I Lung Cancer After Segmentectomy with a Close Resection Margin

  • Kim, Dae Hyeon (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital) ;
  • Na, Kwon Joong (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital) ;
  • Park, In Kyu (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital) ;
  • Kang, Chang Hyun (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital) ;
  • Kim, Young Tae (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital) ;
  • Park, Samina (Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital)
  • Received : 2021.05.14
  • Accepted : 2021.07.27
  • Published : 2021.10.05

Abstract

Background: In general, a 2-cm surgical margin is recommended for limited resection to obtain equivalent oncologic outcomes to lobectomy for lung cancer. This study aimed to examine the patterns of recurrence and prognostic factors for recurrence in patients with a close parenchymal resection margin. Methods: From January 2009 to April 2017, 156 patients with stage I lung cancer who underwent segmentectomy with a close resection margin (<2 cm) were enrolled. Recurrence-free survival and overall survival were assessed. In addition, predisposing factors for recurrence were evaluated. Results: The mean tumor size was 1.7±0.8 cm and the parenchymal resection margin was 1.1±0.6 cm. Recurrence developed in 17 (10.7%) of the 156 patients, and the 5-year recurrence-free survival rate was 88.9%. Distant metastasis (7.7%) was the predominant recurrence pattern. The isolated local recurrence rate was 1.9%. Multivariate Cox regression analysis revealed that age, tumor size, mediastinal lymph node dissection, postoperative complications, and histologic type were significant predisposing factors for recurrence. However, parenchymal margin distance did not significantly affect the long-term prognosis. Conclusion: Segmentectomy with a close resection margin for early-stage lung cancer in selected patients resulted in acceptable recurrence and survival. However, patients with tumors larger than 2 cm, squamous cell carcinoma histology, and insufficient mediastinal evaluation should be carefully followed up for recurrence.

Keywords

References

  1. Chen T, Luo J, Wang R, et al. Prognosis of limited resection versus lobectomy in elderly patients with invasive lung adenocarcinoma with tumor size less than or equal to 2 cm. J Thorac Dis 2018;10:2231-9. https://doi.org/10.21037/jtd.2018.04.47
  2. Schuchert MJ, Pettiford BL, Keeley S, et al. Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg 2007;84:926-33. https://doi.org/10.1016/j.athoracsur.2007.05.007
  3. Nakamura K, Saji H, Nakajima R, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol 2010;40:271-4. https://doi.org/10.1093/jjco/hyp156
  4. Lim TY, Park S, Kang CH. A meta-analysis comparing lobectomy versus segmentectomy in stage I non-small cell lung cancer. Korean J Thorac Cardiovasc Surg 2019;52:195-204. https://doi.org/10.5090/kjtcs.2019.52.4.195
  5. National Comprehensive Cancer Network. Non-small cell lung cancer (version 4.2021) [Internet]. Plymouth Meeting (PA): National Comprehensive Cancer Network; 2021 [cited 2021 Mar 3]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.
  6. Landreneau RJ, Normolle DP, Christie NA, et al. Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis. J Clin Oncol 2014;32:2449-55. https://doi.org/10.1200/JCO.2013.50.8762
  7. Brown LM, Louie BE, Jackson N, Farivar AS, Aye RW, Vallieres E. Recurrence and survival after segmentectomy in patients with prior lung resection for early-stage non-small cell lung cancer. Ann Thorac Surg 2016;102:1110-8. https://doi.org/10.1016/j.athoracsur.2016.04.037
  8. Whitson BA, Groth SS, Andrade RS, Maddaus MA, Habermann EB, D'Cunha J. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis. Ann Thorac Surg 2011;92:1943-50. https://doi.org/10.1016/j.athoracsur.2011.05.091
  9. Lutz JA, Seguin-Givelet A, Grigoroiu M, Brian E, Girard P, Gossot D. Oncological results of full thoracoscopic major pulmonary resections for clinical stage I non-small-cell lung cancer. Eur J Cardiothorac Surg 2019;55:263-70. https://doi.org/10.1093/ejcts/ezy245
  10. Kozu Y, Maniwa T, Takahashi S, Isaka M, Ohde Y, Nakajima T. Risk factors for both recurrence and survival in patients with pathological stage I non-small-cell lung cancer. Eur J Cardiothorac Surg 2013;44:e53-8. https://doi.org/10.1093/ejcts/ezt192
  11. El-Sherif A, Fernando HC, Santos R, et al. Margin and local recurrence after sublobar resection of non-small cell lung cancer. Ann Surg Oncol 2007;14:2400-5. https://doi.org/10.1245/s10434-007-9421-9
  12. Sawabata N, Ohta M, Matsumura A, et al. Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: a multicenter prospective study. Ann Thorac Surg 2004;77:415-20. https://doi.org/10.1016/S0003-4975(03)01511-X
  13. Maurizi G, D'Andrilli A, Ciccone AM, et al. Margin distance does not influence recurrence and survival after wedge resection for lung cancer. Ann Thorac Surg 2015;100:918-25. https://doi.org/10.1016/j.athoracsur.2015.04.064
  14. Wolf AS, Swanson SJ, Yip R, et al. The impact of margins on outcomes after wedge resection for stage I non-small cell lung cancer. Ann Thorac Surg 2017;104:1171-8. https://doi.org/10.1016/j.athoracsur.2017.04.024
  15. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409. https://doi.org/10.1056/NEJMoa1102873
  16. Suzuki K, Koike T, Shibata T, et al. Evaluation of radiologic diagnosis in peripheral clinical IA lung cancers: a prospective study for radiological diagnosis of peripheral early lung cancer (JCOG 0201). J Clin Oncol 2006;24(18_suppl):7220. https://doi.org/10.1200/jco.2006.24.18_suppl.7220
  17. Xue W, Duan G, Zhang X, Zhang H, Zhao Q, Xin Z. Meta-analysis of segmentectomy versus wedge resection in stage IA non-small-cell lung cancer. Onco Targets Ther 2018;11:3369-75. https://doi.org/10.2147/OTT.S161367
  18. Schuchert MJ, Abbas G, Awais O, et al. Anatomic segmentectomy for the solitary pulmonary nodule and early-stage lung cancer. Ann Thorac Surg 2012;93:1780-7. https://doi.org/10.1016/j.athoracsur.2011.11.074
  19. Mimae T, Okada M. Are segmentectomy and lobectomy comparable in terms of curative intent for early stage non-small cell lung cancer? Gen Thorac Cardiovasc Surg 2020;68:703-6. https://doi.org/10.1007/s11748-019-01219-y
  20. Suzuki K, Watanabe S, Mizusawa J, et al. Predictors of non-neoplastic lesions in lung tumours showing ground-glass opacity on thin-section computed tomography based on a multi-institutional prospective study. Interact Cardiovasc Thorac Surg 2015;21:218-23. https://doi.org/10.1093/icvts/ivv124
  21. Altorki NK, Wang X, Wigle D, et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med 2018;6:915-24. https://doi.org/10.1016/S2213-2600(18)30411-9
  22. Thunnissen E. Pulmonary adenocarcinoma histology. Transl Lung Cancer Res 2012;1:276-9. https://doi.org/10.3978/j.issn.2218-6751.2012.10.11
  23. Yoshida J, Ishii G, Yokose T, et al. Possible delayed cut-end recurrence after limited resection for ground-glass opacity adenocarcinoma, intraoperatively diagnosed as Noguchi type B, in three patients. J Thorac Oncol 2010;5:546-50. https://doi.org/10.1097/JTO.0b013e3181d0a480
  24. Watanabe K, Tsuboi M, Sakamaki K, et al. Postoperative follow-up strategy based on recurrence dynamics for non-small-cell lung cancer. Eur J Cardiothorac Surg 2016;49:1624-31. https://doi.org/10.1093/ejcts/ezv462
  25. Demicheli R, Fornili M, Ambrogi F, et al. Recurrence dynamics for non-small-cell lung cancer: effect of surgery on the development of metastases. J Thorac Oncol 2012;7:723-30. https://doi.org/10.1097/JTO.0b013e31824a9022
  26. Takahashi Y, Miyajima M, Tada M, Maki R, Mishina T, Watanabe A. Outcomes of completion lobectomy long after segmentectomy. J Cardiothorac Surg 2019;14:116. https://doi.org/10.1186/s13019-019-0941-8
  27. Sienel W, Stremmel C, Kirschbaum A, et al. Frequency of local recurrence following segmentectomy of stage IA non-small cell lung cancer is influenced by segment localisation and width of resection margins: implications for patient selection for segmentectomy. Eur J Cardiothorac Surg 2007;31:522-8. https://doi.org/10.1016/j.ejcts.2006.12.018
  28. Masai K, Sakurai H, Sukeda A, et al. Prognostic impact of margin distance and tumor spread through air spaces in limited resection for primary lung cancer. J Thorac Oncol 2017;12:1788-97. https://doi.org/10.1016/j.jtho.2017.08.015